Gary Ulaner
机构: Hoag Family Cancer Institute, Newport Beach, California
每年引用次数
引用次数
引用: 9,306
H-指数: 48
I10-指数 : 111
出版物: 269
Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts
Linda C. Giudice , Andrew R. Hoffman , Thanh H. Vu , Ji-Fan Hu
Cancer Research 58 ( 18) 4168 -4172
451
1998
Visualization of Telomerase Reverse Transcriptase (hTERT) Promoter Activity Using a Trimodality Fusion Reporter Construct
Ramasamy Paulmurugan , Sanjiv S. Gambhir , Sandip Biswal , Parasuraman Padmanabhan
The Journal of Nuclear Medicine 47 ( 2) 270 -277
27
2006
Absence of a Telomere Maintenance Mechanism as a Favorable Prognostic Factor in Patients with Osteosarcoma
Leah Ben-Porat , Marc Ladanyi , Jaya M. Satagopan , Andrew G. Huvos
Cancer Research 63 ( 8) 1759 -1763
209
2003
Author Correction: Accelerated single cell seeding in relapsed multiple myeloma.
Elli Papaemmanuil , Neha S. Korde , Neha S. Korde , Gary A. Ulaner
Nature Communications 12 ( 1) 591 -591
2021
Improved image reconstruction of 89 Zr-immunoPET studies using a Bayesian penalized likelihood reconstruction algorithm.
Joseph A. O’Donoghue , Anton S. Becker , Gary A. Ulaner , Gary A. Ulaner
EJNMMI Physics 8 ( 1) 6 -6
2021
Evidence-Based Best Practices: 18F-FDG PET Staging of Newly Diagnosed Breast Cancer.
David Groheux , Heather A. Jacene , Ashwin Singh Parihar , Gary A. Ulaner
Clinical Nuclear Medicine 46 ( 7) 569 -570
2021
Pathologically Benign Lymph Nodes Can Mimic Malignancy on Imaging in Patients With Angiomatoid Fibrous Histiocytoma.
Gary A. Ulaner , John H. Healey , Edward A. Athanasian
Clinical Orthopaedics and Related Research 475 ( 9) 2274 -2279
2
2017
Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical Trial
Neil M. Iyengar , Lillian M. Smyth , Diana Lake , Ayca Gucalp
JAMA Network Open 2 ( 11)
3
2019
High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.
Matthias Papo , Eli L. Diamond , Fleur Cohen-Aubart , Jean-François Emile
Blood 130 ( 8) 1007 -1013
49
2017
Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites.
Youwen Yang , Ji-Fan Hu , Gary A. Ulaner , Tao Li
Journal of Cellular Biochemistry 90 ( 5) 1038 -1055
39
2003
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer
Lillian M. Smyth , Sarina A. Piha-Paul , Helen H. Won , Alison M. Schram
Cancer Discovery 10 ( 2) 198 -213
73
2020
HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers
Bob T. Li , Flavia Michelini , Sandra Misale , Emiliano Cocco
Cancer Discovery 10 ( 5) 674 -687
20
2020
Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma
Craig S. Sauter , Matthew J. Matasar , Jessica Meikle , Heiko Schoder
Blood 125 ( 16) 2579 -2581
67
2015
Identifying and Distinguishing Treatment Effects and Complications from Malignancy at FDG PET/CT
Gary A. Ulaner , Ashima Lyall
Radiographics 33 ( 6) 1817 -1834
72
2013
PET/CT for Patients With Breast Cancer: Where Is the Clinical Impact?
Gary A. Ulaner
American Journal of Roentgenology 213 ( 2) 254 -265
12
2019
Telomere maintenance in clinical medicine.
Gary A. Ulaner
The American Journal of Medicine 117 ( 4) 262 -269
44
2004
False-positive FDG PET/CT due to liver parenchymal injury caused by a surgical retractor.
Ashima Lyall , Gary A. Ulaner
Clinical Nuclear Medicine 37 ( 9) 910 -911
7
2012
Hill-Sachs Lesion on FDG PET/CT
Gary A. Ulaner , Sanjit Tewari
Clinical Nuclear Medicine 38 ( 1) 65 -66
2013
Focused Regional FDG PET/CT Detects More Osseous Metastases Than Does Whole-Body PET/CT
Alireza Mojtahedi , Steven B. Solomon , Gary A. Ulaner
Clinical Nuclear Medicine 38 ( 3) 217 -218
1
2013
Breast Implant Foreign Body Reaction Mimicking Breast Cancer Recurrence on FDG PET/CT
Gary A. Ulaner , Gabriella D’Andrea , Hiram S. Cody
Clinical Nuclear Medicine 38 ( 6) 480 -481
10
2013